BATRB (BATRB) short interest & short volume · 442 shares short
BATRB official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
BATRB short interest fell 37.8% to 442 shares in the Oct 15, 2026 report (6.1 days to cover).
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 442
- prior 710
- % of float
- —
- no float on file
- Days to cover
- 6.1
- avg vol 72
- Change vs prior report
- -37.8%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
No FINRA daily short volume on file for BATRB yet.
Short squeeze score (model)
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
BATRB's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · BATRB overview
BATRB short interest FAQ
What is BATRB's short interest?
BATRB had 442 shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does BATRB have?
6.1 days: 442 shares short divided by an average daily volume of 72 for the Oct 15, 2026 period.
Is BATRB short interest rising or falling?
BATRB short interest fell (-37.8%) from 710 to 442 shares in the Oct 15, 2026 report.
Is BATRB a short squeeze candidate?
Lician's squeeze watch scores BATRB 15 out of 100 (low) from the Oct 15, 2026 report: days to cover 15.4/25, change in short interest vs prior report 0/15. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
Not investment advice. Figures as filed or reported, not a live feed.